Citation Tools
Immune cell therapies and immune cell engineering
Original research
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
